Eye Catching Stock News: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) spotted trading -23.75% off 52-week high price. On the other end, the stock has been noted 27.28% away from the low price over the last 52-weeks. The stock changed 4.10% to recent value of $5.33. The stock transacted 23961 shares during most recent day however it has an average volume of 15.43K shares. The company has 15.12M of outstanding shares and 8.63M shares were floated in the market.

On Jan. 7, 2020, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) a specialty pharmaceutical company with a focus on hospital acute care, disclosed the launch of Caldolor® (ibuprofen) Injection in a ready-to-use bag that may be administered without dilution for pain relief. This launch follows FDA approval in 2019 of the product’s new delivery method.

A non-steroidal anti-inflammatory drug (NSAID), Caldolor may be used as the sole method of treatment for mild-moderate pain or as part of a multi-modal treatment for severe pain. Thus it is positioned to play an important role in combatting the nation’s opioid crisis, which claims the lives of over 130 Americans a day, according to The Centers for Disease Control and Prevention.

Even short-term opioid use after surgery can lead to long-term addiction. Prompt and appropriate pain management is vital to mitigating opioid use. Published data for Caldolor supports administration just prior to surgery and throughout the postoperative period. As a result patients experience significantly less pain upon awakening, then remain in significantly less pain, while also reducing their opioid consumption.

Its earnings per share (EPS) expected to touch remained 12.20% for this year while earning per share for the next 5-years is expected to reach at 30.00%. CPIX has a gross margin of 82.50% and an operating margin of -10.20% while its profit margin remained -10.10% for the last 12 months.

According to the most recent quarter its current ratio was 2.3 that represents company’s ability to meet its current financial obligations. The price moved ahead of 3.17% from the mean of 20 days, 2.95% from mean of 50 days SMA and performed -5.44% from mean of 200 days price. Company’s performance for the week was 11.04%, 3.29% for month and YTD performance remained 3.50%.

Leave a Reply

Your email address will not be published. Required fields are marked *